These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 11910829)

  • 21. Synthesis and antibacterial activity of 6-O-arylpropargyl-9-oxime-11,12-carbamate ketolides.
    Beebe X; Yang F; Bui MH; Mitten MJ; Ma Z; Nilius AM; Djuric SW
    Bioorg Med Chem Lett; 2004 May; 14(10):2417-21. PubMed ID: 15109624
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Recent drug administration methods for respiratory infections].
    Matsumoto K; Iwagaki A
    Nihon Naika Gakkai Zasshi; 1991 May; 80(5):675-80. PubMed ID: 1651973
    [No Abstract]   [Full Text] [Related]  

  • 23. [Efficacy trial in general practice substantiated. New antibiotic with strong effectiveness and tolerance].
    MMW Fortschr Med; 2002 Oct; 144(42):60-1. PubMed ID: 12534000
    [No Abstract]   [Full Text] [Related]  

  • 24. Quinolones and macrolides: roles in respiratory infections.
    Khan FA
    Hosp Pract (Off Ed); 1993 Jan; 28(1):149-153, 156-62. PubMed ID: 8380424
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Telithromycin: the first ketolide antibacterial for the treatment of community-acquired respiratory tract infections.
    Lorenz J
    Int J Clin Pract; 2003; 57(6):519-29. PubMed ID: 12918892
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Acute respiratory tract infection in chronically ill patients. germ spectrum different than in healthy persons].
    MMW Fortschr Med; 2003 Dec; 145(49):61. PubMed ID: 14964003
    [No Abstract]   [Full Text] [Related]  

  • 27. In vitro activity of the new ketolide telithromycin and other antibiotics against Streptococcus pneumoniae in Belgium.
    Verhaegen J; Verbist L
    Acta Clin Belg; 2001; 56(6):349-53. PubMed ID: 11881319
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Macrolides in the treatment of respiratory infection].
    Pahissa A
    Enferm Infecc Microbiol Clin; 1994 Nov; 12(9):423-5. PubMed ID: 7811767
    [No Abstract]   [Full Text] [Related]  

  • 29. [Macrolides, ketolides and streptogramins].
    Mensa J; García-Vázquez E; Vila J
    Enferm Infecc Microbiol Clin; 2003 Apr; 21(4):200-7; quiz 208, 219. PubMed ID: 12681133
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Impact of ketolides on resistance selection and ecologic effects during treatment for respiratory tract infections.
    Nord CE; Farrell DJ; Leclercq R
    Microb Drug Resist; 2004; 10(3):255-63. PubMed ID: 15383171
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Antibiotic resistance of S. pneumoniae and H. influenzae strains isolated from patients with community acquired respiratory tract infections. BACTRO multicenter, multidisciplinary study].
    Tudose C; Bumbăcea D; Bogdan M;
    Pneumologia; 2011; 60(1):30-5. PubMed ID: 21548198
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparative in vitro activity of telithromycin and beta-lactam antimicrobials against bacterial pathogens from community-acquired respiratory tract infections: data from the first year of PROTEKT (1999-2000).
    Kohno S; Hoban D;
    J Chemother; 2003 Aug; 15(4):335-41. PubMed ID: 12962361
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Trends in antibacterial resistance among Streptococcus pneumoniae isolated in the USA: update from PROTEKT US Years 1-4.
    Jenkins SG; Brown SD; Farrell DJ
    Ann Clin Microbiol Antimicrob; 2008 Jan; 7():1. PubMed ID: 18190701
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Macrolide antibiotics: Streptococcus pneumoniae and Haemophilus influenzae].
    Soriano F; Fernández-Roblas R
    Enferm Infecc Microbiol Clin; 1996 Oct; 14(8):503-4. PubMed ID: 9011211
    [No Abstract]   [Full Text] [Related]  

  • 35. [Significant role of penem antibiotics: focused on faropenem (discussion)].
    Saito A; Moritono S; Arata J; Saito A
    Jpn J Antibiot; 1997 Jul; 50(7):579-90. PubMed ID: 9743904
    [No Abstract]   [Full Text] [Related]  

  • 36. Clinical management of respiratory tract infections in the community: experience with telithromycin.
    Quintiliani R
    Infection; 2001 Dec; 29 Suppl 2():16-22. PubMed ID: 11785852
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Ketolide antibiotics. A new therapeutic option in respiratory tract infections].
    MMW Fortschr Med; 2001 Sep; 143(35-36):53-4. PubMed ID: 11584533
    [No Abstract]   [Full Text] [Related]  

  • 38. Clinical implications of macrolide resistance in community-acquired respiratory tract infections.
    Hoban DJ; Zhanel GG
    Expert Rev Anti Infect Ther; 2006 Dec; 4(6):973-80. PubMed ID: 17181414
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [beta-lactam-antibiotics in the treatment of community-acquired respiratory tract infections with penicillin-resistant pneumococci].
    Brauers J; Ewig S; Kresken M
    Pneumologie; 2002 Oct; 56(10):605-9. PubMed ID: 12375222
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Predicting antibacterial response from pharmacodynamic and pharmacokinetic profiles.
    Nicolau DP
    Infection; 2001 Dec; 29 Suppl 2():11-5. PubMed ID: 11785851
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.